TG THERAPEUTICS, INC. (TGTX) ROI
- 2023-09-30: ROI -19.49%.
- 2022-12-31: ROI -172.53%.
- 2022-09-30: ROI -139.08%.
- 2021-12-31: ROI -114.16%.
Complete source-backed roi history.
- Available history
- 2019-03-31 to 2023-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2023-09-30 | -19.49% |
| 2022-12-31 | -172.53% |
| 2022-09-30 | -139.08% |
| 2021-12-31 | -114.16% |
| 2021-09-30 | -95.78% |
| 2021-06-30 | -78.90% |
| 2021-03-31 | -63.08% |
| 2020-12-31 | -50.87% |
| 2020-09-30 | -115.18% |
| 2020-06-30 | -91.88% |
| 2019-12-31 | -255.78% |
| 2019-09-30 | -6344.34% |
| 2019-06-30 | -381.56% |
| 2019-03-31 | -351.51% |
Annual ROI
| Date | ROI |
|---|---|
| 2022-12-31 | -172.53% |
| 2021-12-31 | -114.16% |
| 2020-12-31 | -50.87% |
| 2019-12-31 | -255.78% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |